Guideline Profile : Atopic dermatitis

You are here : Home > Formulary Search > Guideline Profile : Atopic dermatitis

Documentation

Guidelines (Local)

Atopic Dermatitis treatment pathway updated July 2025

Drugs

Below are listed all drugs that are used to treat Atopic dermatitis.

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the reviewed and updated Atopic Dermatitis immunomodulator treatment pathway.

Guideline Profile

Indication :

Atopic dermatitis

Keywords :

JAK, Janus-associated tyrosine kinase , Interleukin, immunomodulator, AD, dermatology, interleukin-4, interleukin-13, IL31

Brand Names Include :

Dupilumab, upadacitinib, abrocitinib, lebrikizumab, tralokinumab, baricitinib, Dupixent, Adtralza, Cibinqo, Rinvoq, Olumiant, Ebglyss, nemolizumab, Nemluvio

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Supporting Documents :